Cancer Treatment Start-Date Evaluation With Synthetic Controls

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing observational studies face challenges in accurately evaluating the effectiveness of cancer treatments due to confounding variables, making it difficult to compare treatment and control groups and assess treatment efficacy with precision.

Innovation Solution

A propensity scoring model is used to identify a synthetic control group with similar characteristics to the treatment group, allowing for precise comparison by adjusting propensity value thresholds and generating survival curves based on event start dates and anchor points, using demographic, clinical, and genomic features.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If propensity scoring is used to match treatment and control groups, then comparison precision is improved, but model complexity increases

Engineering Contradiction:
Improvecomparison precisionVSAvoidmodel complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent introduces propensity scores as an intermediary variable that mediates the comparison between treatment and control groups. By calculating propensity scores based on patient characteristics and using them to match or weight groups, the method achieves precise comparison while managing complexity through a structured statistical framework rather than direct complex modeling of all confounding variables

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent transforms the complex problem of comparing treatment effects into a parameter-based approach by calculating propensity scores that summarize multiple patient characteristics into a single matching parameter. This parameter transformation simplifies the comparison process while maintaining precision by ensuring balanced distribution of confounding variables across groups

Inventive Principle:
Principle #35Parameter changes

2Reliability

If multiple patient characteristics are considered for matching, then evaluation accuracy is improved, but computational complexity increases

Engineering Contradiction:
Improveevaluation accuracyVSAvoidcomputational complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent transforms multiple patient characteristics (age, gender, disease stage, etc.) into a single propensity score parameter through statistical modeling. This parameter transformation allows comprehensive consideration of multiple characteristics while simplifying computation by reducing dimensionality, enabling efficient matching and comparison without requiring complex multi-dimensional analysis

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If propensity value threshold is adjusted to refine group selection, then group similarity is improved, but sample size decreases

Engineering Contradiction:
Improvegroup similarityVSAvoidsample size
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent implements a dynamic propensity value threshold that can be adjusted based on study requirements and data characteristics. This dynamic approach allows researchers to optimize the balance between group similarity and sample size by selecting appropriate threshold values, rather than using a fixed threshold that may be too strict or too lenient for different contexts

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent treats the propensity value threshold as a可调 parameter that can be optimized to achieve desired group similarity while maintaining adequate sample size. By adjusting this parameter, researchers can control the stringency of matching criteria, allowing flexible balance between precision and statistical power based on specific study needs

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12412665B2Methods for evaluating the effect of the start date for cancer treatment with a cancer medication using propensity scoring
Publication Date: 2025.09.09 TEMPUS AI INC
  • US12412665B2 patent drawing
  • US12412665B2 patent drawing
  • US12412665B2 patent drawing

AI summary

An evaluation of a cancer treatment start date for a cancer medication identifies a first plurality of subjects and, for each, the treatment start date. A subject is selected for a second plurality of subjects by applying features for the subject to a model at a propensity value threshold. One subset of the features is associated with a time period and another subset is static. The applying obtains anchor point predictions, each associated with a time in the time period and including a probability that the time is the start date. The time of the anchor point prediction having the greatest probability is assigned the anchor point of the subject. The start date is evaluated with a survival objective based on the start date for each subject in the first plurality and the assigned anchor point for each subject in the second plurality.